Diabetes and Metabolism

David Ann, Ph.D. 
David Ann, professor of the Department of Diabetes Complications & Metabolism, received his PhD from Purdue University. His laboratory is investigating cancer metabolism to identify novel nutrient-restriction cancer therapy. A major focus of his team is to dissect the molecular mechanism by which tumor cells become auxotrophic for arginine.
 
Sangeeta Dhawan, Ph.D. 
Sangeeta Dhawan, assistant professor of the Department of Translational Research & Cellular Therapeutics, received her PhD from Indian Institute of Science. Her laboratory focuses on identifying the epigenetic mechanisms that regulate the differentiation, regeneration and survival of the insulin producing beta cells, in health and diabetes.      
 
Patrick Fueger, Ph.D. 
Patrick Fueger, associate professor of the Department of Molecular & Cellular Endocrinology, received his PhD from Vanderbilt University. His laboratory is investigating molecular mechanisms that regulate glucose homeostasis during health and diabetes to identify novel strategies for increasing functional pancreatic islet mass. 
 
Wendong Huang, Ph.D. 
Wendong Huang, professor of the Department of Diabetes Complications & Metabolism, received his PhD from University of Texas Houston. His team is interested in identifying the molecular pathways by a group of nuclear receptors in regulating metabolism and in the pathogenesis of diabetes and cancer.    
 
Janice Huss, Ph.D. 
Janice Huss, associate professor of the Department of Molecular & Cellular Endocrinology, received her PhD from University of Wisconsin-Madison. Her laboratory is investigating how the estrogen-related receptor family of orphan receptors regulates mitochondrial energy metabolism and growth in cardiac and skeletal muscle. 
 
Keiichi Itakura, Ph.D.  
Keiichi Itakura, professor of the Department of Molecular and Cellular Biology, received his PhD from Tokyo Pharmaceutical College. His lab focuses on studies of the MRF-1/2 genes in modulating the energy utilization pathways and their roles in obesity and diabetes. Understanding the mechanisms related to these proteins is of primary interest.
 
Lei Jiang, Ph.D. 
Lei Jiang, assistant professor of the Department of Molecular & Cellular Endocrinology, received his PhD from Shanghai Institute for Biological Sciences. A major goal of his laboratory is to explore the coordinated metabolic adaptation under both normal physiological and specific pathological conditions for both cancer and diabetes. 
 
John Kaddis, Ph.D. 
John Kaddis, assistant professor of the Department of Diabetes and Cancer Discovery Science, received his PhD from USC. He is currently focused on developing data systems and tools to address leading-edge questions relating to type 1 diabetes.
 
Fouad Kandeel, M.D., Ph.D. 
Fouad Kandeel, professor and chair of the Department of Clinical Diabetes, Endocrinology & Metabolism. His work focuses on diabetes. He is testing the safety and efficacy of islet cell transplantation for type 1 diabetic patients and is also interested in understanding genetic factors contributing to type 2 diabetes and cardiovascular disease in Hispanics.
 
Hsun Teresa Ku, Ph.D.  
Hsun Teresa Ku, associate professor of the Department of Translational Research & Cellular Therapeutics, received her PhD from Medical University of South Carolina. Her research in type 1 diabetes focuses on developing cell replacement therapy and identifying small molecules that modulate pancreatic insulin-producing beta cells and their progenitors.
 
Ke Ma, M.D., Ph.D. 
Ke Ma, associate professor of the Department of Diabetes Complications & Metabolism, received her PhD from Baylor College of Medicine. Her team studies the regulatory networks mediating nutrient-sensing functions of circadian clock in tissue crosstalk between fat, muscle and liver in normal and pathological conditions.
 
Rama Natarajan, Ph.D. 
Rama Natarajan, the National Business Products Industry Profsesor in Diabetes Research, and professor and chair of the Department of Diabetes Complications & Metabolism, received her PhD from Indian Institute of Science. The major focus of her research is to determine the molecular mechanisms involved in the accelerated development of inflammation, vascular and renal complications under diabetic conditions.    
 
Joyce Niland, Ph.D. 
Joyce Niland, the Estelle & Edward Alexander Chair in Information Sciences, and professor and chair of the Department of Diabetes & Cancer Discovery Science, received her PhD from USC. She is principal investigator of the Human Islet Research Network Coordinating Center and the Integrated Islet Distribution Program to facilitate efficient use of these resources within the diabetes community for studying and treating type 1 diabetes. 
 
Helena Reijonen, Ph.D.  
Helena Reijonen, associate professor of the Department of Diabetes Immunology, received her PhD from University of Oulu and University of Turku. Her research is directed at understanding the autoimmunity response that leads to type 1 diabetes and limits the treatment of the disease following pancreatic islet cell transplantation.  
 
Arthur Riggs, Ph.D.  
Arthur Riggs, the Samuel Rahbar Chair in Diabetes & Drug Discovery and director of the Diabetes & Metabolism Research Institute at City of Hope, received his PhD from California Institute of Technology. His laboratory is focused on how gene regulation occurs via chromatin-based mechanisms and how this regulation changes during mammalian development.
 
Bart Roep, M.D., Ph.D. 
Bart Roep, the Chan Soon-Shiong Shapiro Distinhuished Chair in Diabetes and chair of the Department of Diabetes Immunology, received his PhD from Leiden University. His laboratory focuses on understanding the cause of immune response to insulin-producing beta cells and developing new strategy to modulate and desensitize immune response to beta cells for the cure of type 1 diabetes.
 
Hung-Ping (Ben) Shih, Ph.D. 
Hung-Ping Shih, assistant professor of the Department of Translational Research & Cellular Therapeutic, received his PhD from Oregon State University. His laboratory focuses on defining the molecular control of organ morphogenesis and the interplay between morphogenesis and cell-fate decisions during pancreatic development. 
 
Debbie Thurmond, Ph.D.  
Debbie Thurmond, the Ruth B. & Robert K. Lanman Chair in Gene Regulation and Drug Discovery, and professor and chair of the Department of Molecular & Cellular Endocrinology, received her PhD from University of Iowa. Her research focuses on understanding the cellular and molecular mechanisms involved with diabetes development and identifying therapies to reverse the progression of the disease.
 
Rupangi Vasavada, Ph.D. 
Rupangi Vasavada, associate professor of the Department of Translational Research & Cellular Therapeutics, received her PhD from University of Pennsylvania. Her work focuses on understanding how biological peptides may enhance the preservation and regeneration of functional beta cells as a treatment for diabetes.  
 
Qiong (Annabel) Wang Ph.D. 
Qiong Wang, assistant professor of the Department of Molecular & Cellular Endocrinology. Her team focuses on defining the mechanisms of adipose tissue remodeling in mammary glands to prevent metabolic disorders and breast cancer, as well as brown adipocyte heterogeneity in remodeling the energy-burning capacity in brown adipocytes. 
 
Jiing-Kuan Yee, Ph.D. 
Jiing-Kuan Yee, professor of the Department of Diabetes Complications & Metabolism, received his PhD from University of Texas Dallas. His laboratory focuses on developing novel human pluripotent stem cell differentiation protocol to produce functional beta islet cells in clinical relevant quality and quantity for the treatment of diabetes.